V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009891 | 260006296 | null | 58.8 | Disease modification (D) | 2018-02-26 | 2018-03-10 | R Chlorambucil | N | N | 260011489 | CISPLATIN |
| 260009892 | 260006296 | 1.77 | 90.999 | Disease modification (D) | 2016-03-03 | 2016-03-10 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260011489 | TIP |
| 260009893 | 260006297 | 1.8 | 114 | Adjuvant (A) | 2013-10-14 | 2013-10-19 | Carboplatin + Etoposide iv&po | 02 | N | 260011651 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260009894 | 260012411 | 1.63 | 63.5 | Disease modification (D) | 2016-09-03 | 2016-09-04 | Cisplatin + Etoposide po&iv 3 day | 2 | N | 260011685 | RITUXIMAB |
| 260009895 | 260012411 | 0 | 90.4 | Curative (C) | 2016-07-16 | 2016-08-15 | Cisplatin + Etoposide (5 day) | N | N | 260011685 | CISPLATIN + ETOPOSIDE |
| 260009896 | 260006298 | 1.79 | 102.3 | null | 2015-07-12 | 2015-07-28 | CISPLATIN + ETOPOSIDE | 99 | null | 260011769 | PACIFICO TRIAL |
| 260009897 | 260006298 | 1.74 | null | Palliative (P) | 2018-11-14 | 2018-12-13 | TIP | N | N | 260011769 | CISPLATIN + ETOPOSIDE |
| 260009898 | 260006299 | 1.8 | 90 | Palliative (P) | 2019-01-18 | 2019-01-18 | Cisplatin + Etoposide (5 day) | N | N | 260011815 | EP |
| 260009899 | 260006300 | 1.83 | 82.6 | null | 2017-08-15 | 2017-08-21 | Cisplatin + Etoposide (5 day) | 2 | null | 260011846 | TIP |
| 260009900 | 260012413 | 1.77 | 86.2 | Palliative (P) | 2017-06-09 | 2017-06-22 | Carboplatin + Etoposide IV 3 day | 2 | N | 260011854 | RITUXIMAB |
| 260009901 | 260012413 | 1.7 | 0 | Palliative (P) | 2015-03-05 | 2015-03-06 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE | 02 | N | 260011854 | CARBOPLATIN + ETOPOSIDE |
| 260009902 | 260012413 | 1.82 | 0 | Palliative (P) | 2015-08-24 | 2015-09-12 | TIP | N | N | 260011854 | CISPLATIN + ETOPOSIDE |
| 260009903 | 260006301 | 1.8 | null | Adjuvant (A) | 2013-12-20 | 2013-12-20 | TIP | N | null | 260011876 | CISPLATIN + ETOPOSIDE |
| 260009904 | 260006301 | 1.8 | null | Disease modification (D) | 2018-10-10 | 2018-10-21 | EP | N | N | 260011876 | ECX |
| 260009905 | 260006302 | 1.93 | 57.6 | Palliative (P) | 2018-02-23 | 2018-02-23 | TIP | 2 | N | 260011893 | CISPLATIN + ETOPOSIDE |
| 260009906 | 260006302 | 1.52 | 82 | Adjuvant (A) | 2014-07-01 | 2014-07-07 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260011893 | RITUXIMAB |
| 260009907 | 260006303 | null | null | Disease modification (D) | 2017-03-20 | 2017-03-27 | TIP | 02 | N | 260011900 | CISPLATIN + ETOPOSIDE |
| 260009908 | 260006304 | 1.69 | 88.1 | Palliative (P) | 2013-11-30 | 2013-12-26 | Rituximab | N | N | 260011916 | RITUXIMAB |
| 260009909 | 260006304 | null | 81 | Curative (C) | 2014-01-21 | 2014-01-27 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | Y | N | 260011916 | TIP |
| 260009910 | 260006305 | null | 73 | Palliative (P) | 2016-11-25 | 2016-11-25 | Cisplatin + Etoposide (5 day) | 02 | null | 260011938 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009911 | 260012417 | 1.72 | 107.4 | null | null | 2017-01-14 | EP | null | null | 260011942 | CISPLATIN + ETOPOSIDE |
| 260009912 | 260012417 | 1.75 | 75 | Curative (C) | 2017-07-25 | 2017-08-23 | Bendamustine +/- Prednisolone | N | N | 260011942 | CISPLATIN + RT |
| 260009913 | 260012417 | null | 56.6 | Curative (C) | null | 2014-12-19 | Cisplatin + Etoposide (3 day) | null | null | 260011942 | CISPLATIN + ETOPOSIDE |
| 260009914 | 260012417 | 1.58 | 91 | Palliative (P) | 2015-06-27 | 2015-06-27 | Cisplatin + Radiotherapy | N | N | 260011942 | CARBOPLATIN + PACLITAXEL |
| 260009915 | 260012417 | 1.74 | null | Curative (C) | 2013-06-07 | 2013-06-08 | Cisplatin + Etoposide (5 day) | Y | null | 260011942 | CISPLATIN + ETOPOSIDE |
| 260009916 | 260012417 | 1.76 | 76.4 | Disease modification (D) | 2015-05-29 | 2015-06-03 | CISPLATIN + ETOPOSIDE | 02 | N | 260011942 | NOT MATCHED |
| 260009917 | 260006306 | 1.73 | 88.8 | Palliative (P) | 2016-05-12 | 2016-05-21 | EP | N | N | 260012087 | CISPLATIN + ETOPOSIDE |
| 260009918 | 260006306 | 1.9 | 69 | Adjuvant (A) | 2018-11-24 | 2018-12-26 | Carboplatin + Etoposide iv&po | 2 | N | 260012087 | NOT MATCHED |
| 260009919 | 260006306 | 1.62 | 79 | Disease modification (D) | 2017-11-07 | 2017-11-15 | ABVD | 02 | N | 260012087 | CARBOPLATIN + VINORELBINE |
| 260009920 | 260006307 | 1.6 | null | Disease modification (D) | 2017-06-12 | 2017-06-16 | Bendamustine +/- Prednisolone | N | N | 260012165 | FEC |
| 260009921 | 260006308 | 1.66 | 73.2 | Palliative (P) | 2017-02-06 | 2017-02-06 | CEB 3 day | N | N | 260012188 | CISPLATIN + ETOPOSIDE |
| 260009922 | 260006308 | 1.73 | null | Curative (C) | 2017-07-24 | 2017-07-25 | Cisplatin + Etoposide (3 day) | Y | N | 260012188 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009923 | 260006309 | 1.78 | 76 | Curative (C) | null | 2018-02-26 | Cisplatin + Etoposide (5 day) | null | null | 260012263 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009924 | 260006309 | 1.6 | null | Palliative (P) | 2018-11-05 | 2018-12-30 | Cisplatin + Etoposide (3 day) | N | N | 260012263 | CISPLATIN + ETOPOSIDE |
| 260009925 | 260006310 | 1.55 | 72 | Curative (C) | 2018-04-05 | 2018-04-06 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260012307 | PACLITAXEL |
| 260009926 | 260006310 | 1.8 | null | Disease modification (D) | 2016-06-03 | 2016-06-06 | ETOPOSIDE | 02 | N | 260012307 | EP |
| 260009927 | 260006310 | 1.78 | 62.4 | Disease modification (D) | 2018-10-09 | 2018-10-11 | GC Int Guide Excranial GermCell JEB | 2 | N | 260012307 | CISPLATIN + ETOPOSIDE |
| 260009928 | 260006311 | 1.64 | 71 | Disease modification (D) | 2018-01-23 | 2018-02-25 | Cisplatin 7 day | 2 | N | 260012333 | RITUXIMAB |
| 260009929 | 260012422 | null | null | Palliative (P) | 2017-01-13 | 2017-01-13 | FCR Oral - Cycle 1 | N | N | 260012345 | RITUXIMAB |
| 260009930 | 260012422 | 1.71 | 62 | Curative (C) | 2015-05-14 | 2015-05-15 | Cisplatin + Etoposide (5 day) | 02 | N | 260012345 | CARBOPLATIN + ETOPOSIDE |
| 260009931 | 260012422 | 1.8 | 131 | Curative (C) | null | 2017-07-21 | Cisplatin + Etoposide (3 day) | N | N | 260012345 | BLEOMYCIN |
| 260009932 | 260006312 | 1.68 | 76 | Disease modification (D) | 2018-02-18 | 2018-02-19 | Rituximab (Maintenance) | N | N | 260012446 | RITUXIMAB |
| 260009933 | 260006312 | 1.76 | 160 | Disease modification (D) | 2018-08-12 | 2018-09-07 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260012446 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009934 | 260006313 | null | 62 | Not known (9) | 2015-04-13 | 2015-04-20 | Rituximab (Maintenance) | null | null | 260012456 | RITUXIMAB |
| 260009935 | 260006314 | 1.47 | 73.1 | null | 2018-08-04 | 2018-08-08 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260012529 | RITUXIMAB |
| 260009936 | 260006314 | null | 70.4 | Curative (C) | 2016-04-08 | 2016-04-28 | CARBOPLATIN + GEMCITABINE | N | N | 260012529 | EC |
| 260009937 | 260006315 | 1.72 | 88 | Palliative (P) | 2017-05-26 | 2018-01-07 | Trial Unspecified | N | N | 260012546 | CISPLATIN + ETOPOSIDE |
| 260009938 | 260012425 | 1.71 | 105 | Curative (C) | 2018-04-02 | 2018-04-03 | Trial Unspecified | 02 | null | 260012552 | TIP |
| 260009939 | 260006316 | 1.77 | 81.8 | null | 2018-07-06 | 2018-07-10 | Cisplatin + Etoposide (5 day) | 02 | null | 260012553 | CISPLATIN + ETOPOSIDE |
| 260009940 | 260012426 | 1.9 | 87.3 | Palliative (P) | 2017-07-18 | 2017-07-20 | ETOPOSIDE | N | N | 260012567 | CISPLATIN + ETOPOSIDE |